PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
10-Jan-2025 Thermo Fisher Scientific’s Olink Platform Selected for World’s Largest Human Proteome Study Thermo Fisher Scientific
10-Jan-2025 Danaher Announces Investment Partnership in Innovaccer Inc. Danaher
10-Jan-2025 Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates AccessWire
10-Jan-2025 Alyea Therapeutics to Present at Biotech Showcase 2025 During 43rd Annual J.P. Morgan Healthcare Conference Week AccessWire
10-Jan-2025 Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations AccessWire
10-Jan-2025 The Ultimate Credentialing Solution for Independent Practitioners: Transform Your Practice in 2025 With CredyApp Solo AccessWire
10-Jan-2025 CD Bioparticles Announces Enhanced Online Ordering System for Improved Customer Experience CD Bioparticles
10-Jan-2025 CD Bioparticles Introduces Endotoxin Free Silver Nanoparticles for Advanced Biomedical Research CD Bioparticles
10-Jan-2025 STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance STEMart
10-Jan-2025 Creative Diagnostics Announces Enhanced Viral Nucleic Acid Residue Assay Kits for Biopharmaceutical Manufacturing Creative Diagnostics
10-Jan-2025 Creative Diagnostics Introduces New Line of Diacetoxyscirpenol Test Reagents Creative Diagnostics
10-Jan-2025 Creative Diagnostics Advances Zika Virus Research with Novel Animal Models Creative Diagnostics
10-Jan-2025 Creative Diagnostics Launches High-Performance HPV IgG ELISA Kit for Accurate and Reliable HPV Antibody Detection Creative Diagnostics
10-Jan-2025 FitSpresso Review: Why Fitspresso Coffee Loophole Is Better Than Other Weight Loss Supplement in 2025? AccessWire
09-Jan-2025 MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test AccessWire
09-Jan-2025 Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness AccessWire
09-Jan-2025 Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment ABIVAX
09-Jan-2025 ClinicMind Ranked #1 for Chiropractic EHR and Practice Management in Black Book Research 2025 User Survey AccessWire
09-Jan-2025 CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis AccessWire
09-Jan-2025 Formycon included in TecDAX Index of Deutsche Börse Formycon AG